These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 38057431

  • 21. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, Nürnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry.
    Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
    [Abstract] [Full Text] [Related]

  • 22. Comparative Genomics of Shiga Toxin-Producing Escherichia coli Strains Isolated from Pediatric Patients with and without Hemolytic Uremic Syndrome from 2000 to 2016 in Finland.
    Bai X, Ylinen E, Zhang J, Salmenlinna S, Halkilahti J, Saxen H, Narayanan A, Jahnukainen T, Matussek A.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0066022. PubMed ID: 35730965
    [Abstract] [Full Text] [Related]

  • 23. Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.
    Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, Humberg A, Benz K, Krause M, Pohl M, Liebau MC, Schild R, Lemke J, Beringer O, Müller D, Härtel C, Wigger M, Vester U, Konrad M, Haffner D, Pape L, Oh J, Kemper MJ.
    Clin Infect Dis; 2017 Jun 15; 64(12):1637-1643. PubMed ID: 28329394
    [Abstract] [Full Text] [Related]

  • 24. Hemolytic uremic syndrome in children.
    Talarico V, Aloe M, Monzani A, Miniero R, Bona G.
    Minerva Pediatr; 2016 Dec 15; 68(6):441-455. PubMed ID: 27768015
    [Abstract] [Full Text] [Related]

  • 25. Is Plasma Exchange Efficacious in Shiga Toxin-Associated Hemolytic Uremic Syndrome? A Narrative Review of Current Evidence.
    Keenswijk W, Raes A, De Clerck M, Vande Walle J.
    Ther Apher Dial; 2019 Apr 15; 23(2):118-125. PubMed ID: 30324646
    [Abstract] [Full Text] [Related]

  • 26. Renal and neurological involvement in typical Shiga toxin-associated HUS.
    Trachtman H, Austin C, Lewinski M, Stahl RA.
    Nat Rev Nephrol; 2012 Nov 15; 8(11):658-69. PubMed ID: 22986362
    [Abstract] [Full Text] [Related]

  • 27. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network.
    Ardissino G, Vignati C, Masia C, Capone V, Colombo R, Tel F, Daprai L, Testa S, Dodaro A, Paglialonga F, Luini M, Brigotti M, Picicco D, Baldioli C, Pagani F, Ceruti R, Tommasi P, Possenti I, Cresseri D, Consonni D, Montini G, Arghittu M, ItalKid-HUS Network.
    J Pediatr; 2021 Oct 15; 237():34-40.e1. PubMed ID: 34197890
    [Abstract] [Full Text] [Related]

  • 28. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.
    Freedman SB, Xie J, Neufeld MS, Hamilton WL, Hartling L, Tarr PI, Alberta Provincial Pediatric Enteric Infection Team (APPETITE), Nettel-Aguirre A, Chuck A, Lee B, Johnson D, Currie G, Talbot J, Jiang J, Dickinson J, Kellner J, MacDonald J, Svenson L, Chui L, Louie M, Lavoie M, Eltorki M, Vanderkooi O, Tellier R, Ali S, Drews S, Graham T, Pang XL.
    Clin Infect Dis; 2016 May 15; 62(10):1251-1258. PubMed ID: 26917812
    [Abstract] [Full Text] [Related]

  • 29. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
    Nitschke M, Sayk F, Härtel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellhöner P, Büning J, Tiemer B, Katalinic A, Rupp J, Lehnert H, Solbach W, Knobloch JK.
    JAMA; 2012 Mar 14; 307(10):1046-52. PubMed ID: 22416100
    [Abstract] [Full Text] [Related]

  • 30. Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial).
    Freedman SB, Schnadower D, Estes M, Casper TC, Goldstein SL, Grisaru S, Pavia AT, Wilfond BS, Metheney M, Kimball K, Tarr PI, Hyperhydration to Improve Kidney Outcomes in children with Shiga Toxin-producing E. Coli infection (HIKO-STEC) Study Team .
    Trials; 2023 May 27; 24(1):359. PubMed ID: 37245030
    [Abstract] [Full Text] [Related]

  • 31. HUS with mutations in CFH and STEC infection treated with eculizumab in a 4-year-old girl.
    Galvez C, Krall P, Rojas A, Oh J, Cano F.
    Pediatr Nephrol; 2023 Apr 27; 38(4):1195-1203. PubMed ID: 35969277
    [Abstract] [Full Text] [Related]

  • 32. [Escherichia coli associated hemolytic and uremic syndrome: what lessons can be learned after the European epidemic of 2011?].
    Lemaignen A, Ridel C, Hertig A, Rondeau E.
    Nephrol Ther; 2013 Jun 27; 9(3):129-36. PubMed ID: 23266201
    [Abstract] [Full Text] [Related]

  • 33. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
    Schwarz C, Brehon A, Mousseaux C, Luque Y, Senet P, Mariani P, Mohamadou I, Zafrani L, Frémeaux-Bacchi V, Rondeau E, Buob D, Rafat C.
    BMC Nephrol; 2020 Jul 11; 21(1):269. PubMed ID: 32652955
    [Abstract] [Full Text] [Related]

  • 34. Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement.
    Wildes DM, Harvey S, Costigan CS, Sweeney C, Twomey É, Awan A, Gorman KM.
    Pediatr Nephrol; 2024 Jan 11; 39(1):315-324. PubMed ID: 37491519
    [Abstract] [Full Text] [Related]

  • 35. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome.
    Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, Rimhanen-Finne R, Nuutinen M, Kataja J, Arikoski P, Linkosalo L, Bai X, Matussek A, Jalanko H, Saxén H.
    Pediatr Nephrol; 2020 Sep 11; 35(9):1749-1759. PubMed ID: 32323005
    [Abstract] [Full Text] [Related]

  • 36. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network.
    Ardissino G, Possenti I, Vignati C, Daprai L, Capone V, Brigotti M, Luini MV, Consonni D, Montini G.
    Pediatr Nephrol; 2020 Oct 11; 35(10):1997-2001. PubMed ID: 32734345
    [Abstract] [Full Text] [Related]

  • 37. Associations Between Hydration Status, Intravenous Fluid Administration, and Outcomes of Patients Infected With Shiga Toxin-Producing Escherichia coli: A Systematic Review and Meta-analysis.
    Grisaru S, Xie J, Samuel S, Hartling L, Tarr PI, Schnadower D, Freedman SB, Alberta Provincial Pediatric Enteric Infection Team.
    JAMA Pediatr; 2017 Jan 01; 171(1):68-76. PubMed ID: 27893870
    [Abstract] [Full Text] [Related]

  • 38. Genome-wide association study of hemolytic uremic syndrome causing Shiga toxin-producing Escherichia coli from Sweden, 1994-2018.
    Matussek A, Mernelius S, Chromek M, Zhang J, Frykman A, Hansson S, Georgieva V, Xiong Y, Bai X.
    Eur J Clin Microbiol Infect Dis; 2023 Jun 01; 42(6):771-779. PubMed ID: 37103716
    [Abstract] [Full Text] [Related]

  • 39. Eculizumab Use in a Temporarily Dialysis-Dependent Patient With Shiga Toxin-Producing Escherichia Coli Hemolytic Uremic Syndrome With Neurological Complications.
    Weber B, Chan D, Hammer S.
    J Pediatr Pharmacol Ther; 2022 Jun 01; 27(1):90-95. PubMed ID: 35002565
    [Abstract] [Full Text] [Related]

  • 40. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
    Peco-Antić A.
    Srp Arh Celok Lek; 2016 Jun 01; 144(11-12):664-9. PubMed ID: 29659236
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.